Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Professor Yang Shi has been elected Fellow of the Academy of the American Association for Cancer Research (AACR), class of 2022.

The AACR is the first and largest cancer research organisation dedicated to accelerating the conquest of cancer. The mission of the AACR Academy is “to recognize and honour distinguished scientists whose scientific contributions have propelled significant innovation and progress against cancer”. Nominees are elected through an annual peer review process conducted by existing Fellows of the AACR Academy and ratified by the AACR Academy Steering Committee and the AACR Executive Committee in conjunction with the AACR Academy Nomination and Election Oversight Committee. This year, 33 new Fellows have been elected, who join 256 existing Fellows, including Ludwig Oxford’s Professor Sir Peter Ratcliffe who was elected in 2020 and visiting Professor Lieping Chen, who was elected in 2021.

Ludwig Oxford’s Professor Yang Shi is recognized for his landmark contributions to the field of epigenetics, which the AACR noted have had a “far-reaching impact on basic and translational cancer research.” These include the transformative demonstration that histone methylation, which controls gene expression, is reversible and dynamically regulated, and the discovery of the first histone demethylase, LSD1, which is now a significant drug target for the treatment of cancer. You can read more about Yang’s research here.

Many congratulations to Yang!

Similar stories

Two new therapeutic targets in tuft cell-like small cell lung cancer

Yang Shi’s group identify two transcriptional co-activators that are selectively important for cancer cell but not normal cell survival.

Ludwig Oxford's Yang Shi elected to National Academy of Medicine

Ludwig Cancer Research congratulates Yang Shi on one of the highest honours in the fields of health and medicine